GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » CardioGenics Holdings Inc (OTCPK:CGNH) » Definitions » Cyclically Adjusted PB Ratio

CardioGenics Holdings (CardioGenics Holdings) Cyclically Adjusted PB Ratio : (As of Jun. 08, 2024)


View and export this data going back to 2004. Start your Free Trial

What is CardioGenics Holdings Cyclically Adjusted PB Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


CardioGenics Holdings Cyclically Adjusted PB Ratio Historical Data

The historical data trend for CardioGenics Holdings's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CardioGenics Holdings Cyclically Adjusted PB Ratio Chart

CardioGenics Holdings Annual Data
Trend Jul06 Jul07 Jul08 Oct09 Oct10 Oct11 Oct12 Oct13 Oct14 Oct15
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

CardioGenics Holdings Quarterly Data
Apr11 Jul11 Oct11 Jan12 Apr12 Jul12 Oct12 Jan13 Apr13 Jul13 Oct13 Jan14 Apr14 Jul14 Oct14 Jan15 Apr15 Jul15 Oct15 Jan16
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of CardioGenics Holdings's Cyclically Adjusted PB Ratio

For the Diagnostics & Research subindustry, CardioGenics Holdings's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CardioGenics Holdings's Cyclically Adjusted PB Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, CardioGenics Holdings's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where CardioGenics Holdings's Cyclically Adjusted PB Ratio falls into.



CardioGenics Holdings Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

CardioGenics Holdings's Cyclically Adjusted Book per Share for the quarter that ended in Jan. 2016 is calculated as:

For example, CardioGenics Holdings's adjusted Book Value per Share data for the three months ended in Jan. 2016 was:

Adj_Book=Book Value per Share/CPI of Jan. 2016 (Change)*Current CPI (Jan. 2016)
=-0.019/100.1844*100.1844
=-0.019

Current CPI (Jan. 2016) = 100.1844.

CardioGenics Holdings Quarterly Data

Book Value per Share CPI Adj_Book
200604 -0.791 86.279 -0.918
200607 -1.048 86.595 -1.212
200610 -0.969 86.121 -1.127
200701 -1.565 86.437 -1.814
200704 -1.745 88.175 -1.983
200707 -2.827 88.491 -3.201
200710 -2.054 88.175 -2.334
200801 0.021 88.333 0.024
200804 -0.032 89.676 -0.036
200807 0.017 91.493 0.019
200810 0.034 90.466 0.038
200901 -0.032 89.281 -0.036
200904 -0.012 89.992 -0.013
200907 0.140 90.624 0.155
200910 0.103 90.545 0.114
201001 0.073 90.940 0.080
201004 0.058 91.651 0.063
201007 0.033 92.283 0.036
201010 0.077 92.757 0.083
201101 0.071 93.074 0.076
201104 0.058 94.654 0.061
201107 -0.016 94.812 -0.017
201110 0.028 95.444 0.029
201201 0.018 95.365 0.019
201204 0.006 96.550 0.006
201207 -0.002 95.997 -0.002
201210 -0.005 96.550 -0.005
201301 -0.012 95.839 -0.013
201304 -0.016 96.945 -0.017
201307 -0.005 97.261 -0.005
201310 -0.016 97.182 -0.016
201401 -0.026 97.261 -0.027
201404 -0.033 98.920 -0.033
201407 -0.047 99.315 -0.047
201410 -0.024 99.473 -0.024
201501 -0.027 98.209 -0.028
201504 -0.020 99.710 -0.020
201507 -0.021 100.579 -0.021
201510 -0.017 100.500 -0.017
201601 -0.019 100.184 -0.019

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


CardioGenics Holdings  (OTCPK:CGNH) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


CardioGenics Holdings Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of CardioGenics Holdings's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


CardioGenics Holdings (CardioGenics Holdings) Business Description

Traded in Other Exchanges
N/A
Address
6295 Northam Drive, Unit 8, Mississauga, ON, CAN, L4V 1W8
CardioGenics Holdings Inc is a biotechnology company. It is engaged in the development and commercialization of diagnostic test products for the In-Vitro Diagnostics (IVD) testing market. The company's objective is to create, develop and commercialize superior, innovative, cost-effective and patent-protected products for the IVD based on proprietary technologies. Its products include QL Care Analyzer, Immunoassay Tests, and Paramagnetic Beads. The business activity is primarily carried out through the region of Canada.

CardioGenics Holdings (CardioGenics Holdings) Headlines

No Headlines